miR-134-5p inhibits osteoclastogenesis through a novel miR-134-5p/Itgb1/MAPK pathway

Meng Huang(Chinese PLA General Hospital), Lulu Xu(Guizhou University), Yu Zhang(Chinese PLA General Hospital), Zhenning Wang(First Hospital of China Medical University), Heyang Zhang(Academy of Military Medical Sciences), Jiantong Cui(PLA Academy of Military Science), Qiaozhen Qin(Beijing Institute of Education), Yan Wang(First Affiliated Hospital of Henan University of Science and Technology), Shuirong Liu(Beijing Institute of Education), Xiaoxia Jiang(Hangzhou Women’s Hospital)
Journal of Biological Chemistry
June 9, 2022
10.1016/j.jbc.2022.102116
Cited by 18

Related Papers

Cloning and Functional Expression of the Human Histamine H<sub>3</sub>Receptor
|Molecular Pharmacology|1999|700
A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone
|Nature Protocols|2010|651
Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H<sub>4</sub>) Expressed in Bone Marrow
|Molecular Pharmacology|2001|408
Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells
|Experimental Hematology|2004|207
Bioadhesive and conductive hydrogel-integrated brain-machine interfaces for conformal and immune-evasive contact with brain tissue
|Matter|2022|189